Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-25-Speech-2-269-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20111025.25.2-269-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I voted in favour of granting discharge to the European Medicines Agency (EMEA), although I regret that some of the requested information was not provided. As a result, we are expecting the agency to inform the discharge authority of the actions implemented and their results, in particular, with a view to overcoming deficiencies in public procurement and managing conflicts of interest which its personnel and experts are exposed to. On this last point, the agency undertook to adopt an approach based on risk and to concentrate verifications on staff members who declare interest. Furthermore, we are asking the agency to be willing to act with regard to carryovers, and we expect to receive confirmation on this from the Court of Auditors. With regard to revenue from fees, the report notes that the agency has invested in software in order to clear the backlog with the recovery orders. Finally, we acknowledge the fact that the agency has revised its cash-flow policy so as to limit risks resulting from fluctuating exchange rates."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples